Additional studies are needed to clarify that this first reported alteration in serum DPP4 activity in COVID-19 is limited only to the original SARS-CoV-2 variant or it also characterizes COVID-19 caused by other virus variants and whether it may help the patient management in the ongoing pandemic . The gene discussed is DPP4; the disease is COVID-19.